Acupuncture in Prevention of Postoperative Sore Throat Due to Classical Laryngeal Mask
NCT ID: NCT04910659
Last Updated: 2021-06-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
200 participants
INTERVENTIONAL
2020-01-01
2021-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Postoperative Oral Cryotherapy in Sore Throat and Daily Life
NCT06249295
Thermosoftening of Double-lumen Tube to Reduce Sore Throat
NCT01626365
The Effect of Cold Vapor on Sore Throat and Dysphagia in the Early Postoperative Period After Suspension Laryngoscopy
NCT05287698
Effect of Pre-emptive Transcutaneous Neuro-muscular Electrical Stimulation for Dysphagia in Long Term Intubated Patients
NCT01202968
Objective and Perceptual Characteristics of the Voice After Endotracheal Intubation in Head and Neck Surgery
NCT07131800
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Using the randomization program, the patients are divided into group 1 (acupuncture group) and group 2 (control group). Preoxygenation (100% oxygen with balloon and mask for 3 minutes) and midozolam 0.02 mg / kg and fentanyl 2 mcgr / kg are administered to both groups. In Group1, laser acupuncture is applied to each of the previously described P6, LI4 and LI 11 points on both arms with laser acupuncture device (Sedatelec Premio 32) for 30 seconds. In Group 2, same procedure is performed for 30 seconds while laser acupuncture closed. Then, propofol 2mg / kg is administered and a laryngeal mask is placed after 90 seconds in both groups. Maintenance anesthesia is provided with sevofurane and remifentanil infusion.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
acupuncture
Group1, laser acupuncture was applied to each of the previously described P6, LI4 and LI 11 points on both arms with laser acupuncture device (Sedatelec Premio 32) for 30 seconds
acupuncture
P6, LI4 and LI 11 stimulation
false acupuncture
P6, LI4 and LI 11 points on both arms with laser acupuncture device (Sedatelec Premio 32) for 30 seconds while laser acupuncture closed
acupuncture
P6, LI4 and LI 11 stimulation
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
acupuncture
P6, LI4 and LI 11 stimulation
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* surgery duration \< 2 hours
* between 18-60 years of age
* ASA1-2 scores
Exclusion Criteria
2. Patients with an ASA score of 3 and greater than 3
3. Active infections in the area to be acupuncture.
4. Prolonged bleeding time
5. Liver failure
6. Renal insufficiency
7. Pregnancy
8. Heart failure 9 . Patients less than 30 kg
10\. Uncontrolled hypertension
11\. Uncontrolled diabetes, pheochrocytoma, thyroid dysfunction
12\. Those who do not have the ability to read and sign the consent form
13\. Patients with gastroesophageal reflux
14\. History of any herbal medicine use
15\. Patients who do not want to sign the consent form
16\. Patients with difficult LMA placement
17.Patients who cannot have LMA placement at one time
18\. Intubated patients in whom LMA could not be placed
19 Patients whose operation time exceeds two hours
20 .Patients whose operation time is less than 30 minutes
18 Years
60 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ankara City Hospital Bilkent
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
FERYAL AKÇAY
Role: PRINCIPAL_INVESTIGATOR
Ankara City Hospital Bilkent
FERYAL AKÇAY
Role: STUDY_CHAIR
Ankara City Hospital Bilkent
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ankara City Hospital Bilkent
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Feryal Akçay
Role: primary
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
E1-19-124
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.